C olonoscopy is a crucial part of any colorectal cancer (CRC) screening strategy because it enables the identification and removal of precancerous and cancerous lesions throughout the entire colon. Recent CRC screening guidelines emphasize quality in colonoscopy (1) . It is recommended that all endoscopists participate in quality assurance programs to ensure that they are operating within quality standards (2) . Quality benchmarks for colonoscopy have been defined in terms of adenoma detection rate (ADR) in screening colonoscopies (3) . It is important for researchers and administrators interested in colonoscopy quality to have reliable means of identifying screening colonoscopies.
Presently, it is difficult to identify colonoscopy indication in health administrative databases due to the lack of codes for screening, underuse and misuse of existing codes, under-reporting of indication and multiple indications for colonoscopy (4) (5) (6) . In studies of the quality of screening colonoscopies, some investigators resorted to other methods of identifying screening procedures including referral physician indication (7), patient-reported characteristics (8, 9) and medical chart review (10) , while other investigators fell short of explicitly describing how screening was defined (11) . We previously reported on the agreement among four different definitions of patient-perceived indication and endoscopist-reported indication (12) ; however, it is unclear how different ways of defining screening would affect ADRs and other quality measures.
The objective of the present study was to estimate polypectomy rates in screening and nonscreening colonoscopies as defined by (13) (14) (15) . For the purposes of both clinical research and quality assessment, it is important to know whether quality measures are sensitive to the way screening is defined.
MethoDS

Data collection
The present cross-sectional analysis combined data from two previously assembled cohort studies. Staff endoscopists at the hospitals were contacted for their consent to participate. To be eligible, the endoscopist was required to have Régie de l'assurance maladie du Québec (RAMQ) colonoscopy billing privileges. Immediately following the procedure, the endoscopist completed a questionnaire that had been attached to the participating patient's file. The questionnaire assessed the indication for colonoscopy (screening, follow-up, diagnostic, surveillance and other).
Consecutive patients who were scheduled for colonoscopy were recruited in the endoscopy waiting room. Inclusion criteria were as follows: 50 to 75 years of age; and scheduled for colonoscopy with a participating endoscopist. Exclusion criteria were as follows: patients not eligible for provincial health insurance coverage; patients without provincial health insurance coverage during the previous year; and those unable to provide informed consent. Eligible and consenting patients were administered a questionnaire that included items on perceived reason for colonoscopy, history of gastrointestinal (GI) conditions, lower abdominal symptoms, previous CRC screening tests and family history of CRC. Patients were asked to provide their health insurance card numbers to facilitate data linkage with RAMQ physician billing records. Extracted from the RAMQ database were data regarding patient age group and sex, and all medical procedures performed on the date of, and up to 30 days after the index colonoscopy. Patient polypectomy status was determined from the presence of the polypectomy billing code on the date of the colonoscopy or within two days after colonoscopy. Polypectomy status obtained from physician billing claims databases is reasonably accurate (16) .
Definitions of colonoscopy indication
Patient indication was classified in four ways (Table 1) (12) . Endoscopist-reported indication (indication 5) was derived from the endoscopist questionnaire. Indications 6 to 9 were based on the agreement between endoscopist indication and patient indications 1 to 4, respectively. For indications 6 to 9, a colonoscopy was considered to be screening only if it was screening by both patient and endoscopist indications, while nonscreening colonoscopies required both patient and endoscopist to suggest nonscreening.
Statistical analyses
Polypectomy rates were estimated using Bayesian hierarchical logistic regression models with random intercepts to account for physician level clustering. All modelling was conducted using WinBUGS version 1.4.3 (WinBUGS, United Kingdom). Estimated polypectomy rates were adjusted to account for the imperfect accuracy of polypectomy reporting in RAMQ physician billing records. Sensitivity and specificity of RAMQ polypectomy code relative to medical chart review has been previously estimated to be 84.7% (95% CI 78.6% to 89.4%) and 99.0% (95% CI 97.5% to 99.6%), respectively (16) . The uncertainties of these estimates were taken into account in the present study by converting the CIs into close-fitting beta densities, which were used in the model as prior distributions for sensitivity and specificity, respectively. Diffuse (noninformative) prior distributions were used for all other parameters. To estimate the effect of each of the indications on polypectomy status, age (ordinal: 50 to 54, 55 to 59, 60 to 64, 65 to 70 and 70 to 75 years), sex and family history of CRC were entered into the hierarchical models. Bayesian 95% credible intervals are reported for all model results.
reSuLtS recruitment statistics
Forty-eight endoscopists consented to study participation, but three were later found to not have RAMQ billing rights and were excluded from further analyses. The remaining 45 physicians were comprised of 38 (84%) gastroenterologists, six (13%) surgeons and one (2%) internist. Of the 2614 patients who were approached, 162 (6%) were ineligible and 236 (9%) of eligible patients declined participation. Of the remaining 2216 (84%) who consented to participate, 82 (4%) were excluded for the following reasons: colonoscopy was performed by a physician without RAMQ billing rights (n=45); individual protocol violation (colonoscopy performed by nonparticipating physicians, noncompletion of colonoscopy, wrong questionnaire used) (n=12); health care card number not found in RAMQ (n=12); consent withdrawn (n=1); patients sampled more than once (n=5); and key questionnaire items missing for patient indication (n=7). In total, data from 2134 (82%) unique patients who underwent colonoscopy were included.
Patient characteristics
Key patient characteristics are summarized in Table 2 . The mean age was 62 years and 50% of the participants were female. Of all patients, 29.4% reported a history of GI conditions, 40.0% experienced lower abdominal symptoms in the previous six months, 23.7% reported a family history of CRC, 2.8% had a positive fecal occult blood test in the past 12 months and 46.4% reported having undergone a colonoscopy in the past 10 years.
Proportion of colonoscopies according to indication
The proportions of colonoscopies classified as screening ranged from 32.2% to 70.9% (Table 3) . Considering indications 1 to 4, progressively fewer colonoscopies were classified as screening. As expected, indications 6 to 9 identified fewer screening procedures compared with indications 1 to 4 because the criteria were more stringent. The endoscopist indication (indication 5) classified 55.1% of colonoscopies as screening. 
Polypectomy rates according to indication
The overall polypectomy rate before adjustment to account for the accuracy of the RAMQ database was 22.7% (95% CI 18.2 to 27.4). Among the different indications, the unadjusted rates ranged from 20% (indication 6) to 22.9% (indication 2) for screening, and from 23.7% (indication 2) to 26.8% (indication 5) for nonscreening colonoscopies. Adjustment consistently increased the polypectomy rate estimates by 2% to 4%. The adjusted rate estimates ranged from 22.6% to 26.2% for screening and 27.1% to 30.8% for nonscreening colonoscopy ( Table 4 ). The median adjusted estimates among the nine indications were 24.2% (indication 8) for screening and 29.9% (indication 6) for nonscreening colonoscopies.
effect of indication on polypectomy
To estimate the effect of indication on polypectomy status, logistic regression was performed for each indication with age, sex and family history of CRC as covariates. Adjustment for covariates did not greatly affect OR estimates compared with univariate models (Table 5) . Adjusted ORs for indication ranged from 0.74 to 0.94.
DiSCuSSioN
We estimated polypectomy rates using nine indications that identified screening and nonscreening colonoscopies based on patient and endoscopist reports. There was considerable variability in the proportion of colonoscopies defined as screening according to indication. Indication 1 (perceived screening) was the most relaxed criterion, while indication 2 (perceived nonscreening) and indication 3 (GI history) were more stringent. Indication 3 is most consistent with the guidelines in which screening is defined as procedures in asymptomatic average-risk individuals (3) . Several recent studies on screening colonoscopy have based their inclusion and exclusion criteria on patient-reported history of GI conditions and symptoms (9, 17, 18) . Indication 4 (combination of 1 to 3) was the most strict of all patient criteria. Indications 6 to 9 were more restrictive than their counterparts in 1 to 4 because they required both patient and endoscopist to agree on screening. The trend observed was consistent with the restrictiveness of the indications, with less stringent indications identifying more screening procedures compared with those that were more stringent. Despite the variation in the number of screening colonoscopies, the indications yielded very similar polypectomy rates for both screening and nonscreening colonoscopies. This may be due to the fact that the rates for screening and nonscreening were comparable. Adjusted polypectomy rates ranged between 22.6% and 26.2% for screening colonoscopy, and between 27.1% and 30.8% for nonscreening. Adjustment for the imperfect accuracy of the polypectomy procedure code raised the polypectomy rates by 3% to 5%. For quality assurance within the province, adjustment may not be necessary. However, because provincial databases will have different accuracies for polypectomy reporting, adjustment is necessary to make results interpretable and comparable across provinces.
From the multivariate models, most ORs for indication as a predictor of polypectomy status were not significant with the exception of indications 5 and 6. Based on the point estimates, the endoscopist and agreement-based indications appear to be better predictors compared with patient indications. However, due to multiple testing and wide CIs around the point estimates, there is insufficient evidence to conclude that these indications are clinically relevant predictors of polypectomy status. Previous studies have reported that indication for colonoscopy is not an important predictor of ADR (19, 20) . Therefore, the shifting of some colonoscopies between screening and nonscreening groups according to indication may not have substantially affected the polypectomy rate estimates. However, it is worth noting that the less restrictive indications (1 to 4) yielded slightly higher estimates for screening and lower rates for nonscreening compared with more restrictive indications, likely by including some nonscreening colonoscopies as screening.
Limitations of our findings include information bias and generalizability issues. All but one of our study sites were tertiary care centres in Montreal, and the findings may not be generalizable to smaller practices or rural settings. The endoscopist indication and the indications derived from it may be subject to reporting bias because the indication was assessed postprocedure when the outcome (polypectomy) was already known to the endoscopist. Also, 46.4% of participants reported having undergone a colonoscopy in the past 10 years. There is growing consensus that previously screened patients are expected to have lower polypectomy rates and ADRs, and that quality benchmarks should apply only to first-time screenees (21). We did not exclude previously screened patients from our analyses because the objective was to compare how indications for screening perform relative to one another, rather than to assess whether benchmarks were met.
The extent to which our conclusions can be extended to ADR relies on the correlation between polypectomy rate and ADR. Studies suggesting that the correlation is high are based on a small number of endoscopists (13) (14) (15) . This correlation may or may not hold true for endoscopists in our study and cannot be verified from the data we collected. However, polypectomy rate has been recently promoted as a more accessible quality measure compared with ADR (14, 15) . Thus, there is significance in our findings independent of ADR.
Strengths of our study include its multicentre design and involvment of more endoscopists than typically included in clinical studies of screening colonoscopy. Thus, our findings are less likely to be influenced by individual endoscopist or institution practices. In addition, we were able to adjust for the imperfect sensitivity and specificity of provincial health databases for polypectomy to obtain more accurate estimates (16) . 
